Pakistan, July 20 -- Thousands of cancer patients in Pakistan are facing difficulties accessing newly registered life-saving medicines as approvals for the prices of 40 drugs remain pending with the federal government. The delay has prevented these medicines from being legally sold in the country, forcing many patients and families to rely on expensive imports and informal supply channels.

Read More: Salman Khan quietly supported cancer patients for over 30 years

One such case involves a young woman suffering from triple-negative breast cancer who has been unable to obtain pembrolizumab, an advanced immunotherapy medicine prescribed after conventional treatments failed. Although the Drug Regulatory Authority of Pakistan (DRAP) has regis...